ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | Former 10% Owner | May 13, 2025 | Sale | $8.06 | 630,191 | 5,079,340 | 2,108,594 | May 15, 2025, 05:32 PM |
HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Mar 27, 2025 | Sale | $1.05 | 2,425 | 2,546 | 4,309,860 | Apr 30, 2025, 04:09 PM |
HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | Mar 27, 2025 | ATM/ITM Option Exercise | $0.09 | 28,113 | 2,530 | 4,312,285 | Apr 30, 2025, 04:09 PM |
TRDA | | Entrada Therapeutics, Inc. | Luke Evnin | 10% Owner | Dec 10, 2024 | Sale | $20.77 | 22,935 | 476,360 | 4,402,849 | Dec 12, 2024, 05:00 PM |
TRDA | | Entrada Therapeutics, Inc. | Luke Evnin | 10% Owner | Dec 11, 2024 | Sale | $20.23 | 21,787 | 440,751 | 4,381,062 | Dec 12, 2024, 05:00 PM |
TCRR | | TCR2 THERAPEUTICS INC. | Luke Evnin | 10% Owner | May 22, 2023 | Sale | $1.88 | 70,170 | 131,920 | 304,001 | May 24, 2023, 04:39 PM |
TCRR | | TCR2 THERAPEUTICS INC. | Luke Evnin | 10% Owner | May 22, 2023 | ATM/ITM Option Exercise | $0.74 | 178,269 | 131,919 | 374,171 | May 24, 2023, 04:39 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Jan 04, 2022 | Sale | $42.66 | 128,550 | 5,483,836 | 2,790,725 | Jan 06, 2022, 04:12 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Jan 05, 2022 | Sale | $42.03 | 18,135 | 762,214 | 2,738,785 | Jan 06, 2022, 04:12 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Dec 03, 2021 | Sale | $34.79 | 20,167 | 701,513 | 2,917,732 | Dec 07, 2021, 06:35 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Dec 06, 2021 | Sale | $32.59 | 10,208 | 332,698 | 2,906,665 | Dec 07, 2021, 06:35 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Dec 07, 2021 | Sale | $33.22 | 19,456 | 646,401 | 2,886,964 | Dec 07, 2021, 06:35 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Nov 30, 2021 | Sale | $35.09 | 33,937 | 1,190,902 | 3,012,959 | Dec 02, 2021, 06:53 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Dec 01, 2021 | Sale | $34.28 | 12,395 | 424,872 | 2,978,841 | Dec 02, 2021, 06:53 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Dec 02, 2021 | Sale | $33.74 | 29,757 | 1,004,001 | 2,942,731 | Dec 02, 2021, 06:53 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Dec 02, 2021 | Sale | $34.83 | 7,430 | 258,787 | 2,935,301 | Dec 02, 2021, 06:53 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Nov 29, 2021 | Sale | $34.49 | 10,371 | 357,656 | 3,019,118 | Nov 30, 2021, 04:53 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Nov 26, 2021 | Sale | $35.75 | 12,674 | 453,110 | 3,035,320 | Nov 30, 2021, 04:53 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Nov 22, 2021 | Sale | $37.52 | 21,114 | 792,271 | 3,110,013 | Nov 24, 2021, 06:34 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Nov 23, 2021 | Sale | $36.22 | 20,004 | 724,449 | 3,078,561 | Nov 24, 2021, 06:34 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Nov 24, 2021 | Sale | $36.29 | 36,337 | 1,318,543 | 3,073,334 | Nov 24, 2021, 06:34 PM |
TRDA | | Entrada Therapeutics, Inc. | Luke Evnin | 10% Owner | Nov 02, 2021 | Conversion | - | 4,325,784 | - | 4,325,784 | Nov 04, 2021, 05:37 PM |
TRDA | | Entrada Therapeutics, Inc. | Luke Evnin | 10% Owner | Nov 02, 2021 | Buy | $20.00 | 100,000 | 2,000,000 | 4,425,784 | Nov 04, 2021, 05:37 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Oct 15, 2021 | Sale | $27.62 | 10,932 | 301,937 | 3,143,197 | Oct 18, 2021, 04:34 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Oct 18, 2021 | Sale | $27.14 | 6,167 | 167,372 | 3,134,991 | Oct 18, 2021, 04:34 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Oct 13, 2021 | Sale | $27.13 | 20,929 | 567,804 | 3,179,410 | Oct 14, 2021, 05:27 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Oct 14, 2021 | Sale | $27.30 | 27,320 | 745,836 | 3,152,090 | Oct 14, 2021, 05:27 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Oct 12, 2021 | Sale | $27.09 | 8,521 | 230,834 | 3,200,339 | Oct 14, 2021, 05:27 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Oct 07, 2021 | Sale | $27.00 | 1,149 | 31,023 | 3,259,704 | Oct 12, 2021, 04:34 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Oct 08, 2021 | Sale | $27.01 | 2,032 | 54,884 | 3,257,672 | Oct 12, 2021, 04:34 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Oct 11, 2021 | Sale | $27.24 | 48,812 | 1,329,639 | 3,208,860 | Oct 12, 2021, 04:34 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Oct 01, 2021 | Sale | $27.00 | 6,855 | 185,085 | 3,281,564 | Oct 05, 2021, 04:32 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Oct 04, 2021 | Sale | $27.06 | 20,711 | 560,440 | 3,260,853 | Oct 05, 2021, 04:32 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Sep 28, 2021 | Sale | $27.00 | 19,214 | 518,778 | 3,290,711 | Sep 30, 2021, 05:06 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Sep 30, 2021 | Sale | $27.00 | 2,292 | 61,884 | 3,288,419 | Sep 30, 2021, 05:06 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Sep 23, 2021 | Sale | $27.97 | 36,930 | 1,032,864 | 3,327,180 | Sep 27, 2021, 05:51 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Sep 24, 2021 | Sale | $27.81 | 4,913 | 136,631 | 3,321,550 | Sep 27, 2021, 05:51 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Sep 27, 2021 | Sale | $27.09 | 11,625 | 314,921 | 3,309,925 | Sep 27, 2021, 05:51 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Sep 21, 2021 | Sale | $27.47 | 19,635 | 539,373 | 3,377,687 | Sep 23, 2021, 04:19 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Sep 22, 2021 | Sale | $27.54 | 14,294 | 393,657 | 3,363,393 | Sep 23, 2021, 04:19 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Sep 16, 2021 | Sale | $28.47 | 21,253 | 605,073 | 3,467,323 | Sep 20, 2021, 06:38 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Sep 17, 2021 | Sale | $28.82 | 45,698 | 1,317,016 | 3,421,625 | Sep 20, 2021, 06:38 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Sep 20, 2021 | Sale | $27.49 | 24,303 | 668,008 | 3,411,023 | Sep 20, 2021, 06:38 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Sep 14, 2021 | Sale | $27.58 | 21,561 | 594,703 | 3,516,303 | Sep 16, 2021, 04:48 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Sep 15, 2021 | Sale | $27.80 | 24,104 | 670,207 | 3,489,567 | Sep 16, 2021, 04:48 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Sep 09, 2021 | Sale | $28.97 | 22,725 | 658,343 | 3,569,156 | Sep 13, 2021, 07:01 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Sep 10, 2021 | Sale | $28.30 | 13,531 | 382,864 | 3,562,396 | Sep 13, 2021, 07:01 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Sep 13, 2021 | Sale | $27.64 | 21,384 | 591,054 | 3,534,241 | Sep 13, 2021, 07:01 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Sep 08, 2021 | Sale | $28.65 | 12,092 | 346,413 | 3,592,821 | Sep 08, 2021, 07:13 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Sep 07, 2021 | Sale | $29.18 | 30,474 | 889,231 | 3,635,313 | Sep 08, 2021, 07:13 PM |
HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | May 04, 2021 | Conversion | - | 3,671,965 | - | 4,133,373 | May 06, 2021, 04:19 PM |
HOWL | | Werewolf Therapeutics, Inc. | Luke Evnin | Director | May 04, 2021 | Buy | $16.00 | 150,799 | 2,412,784 | 4,284,172 | May 06, 2021, 04:19 PM |
HARP | | Harpoon Therapeutics, Inc. | Luke Evnin | Former 10% Owner | Apr 14, 2021 | Sale | $20.77 | 1,671 | 34,714 | 3,223,446 | Apr 15, 2021, 08:01 PM |
HARP | | Harpoon Therapeutics, Inc. | Luke Evnin | Former 10% Owner | Apr 15, 2021 | Sale | $20.49 | 1,052 | 21,555 | 3,220,844 | Apr 15, 2021, 08:01 PM |
HARP | | Harpoon Therapeutics, Inc. | Luke Evnin | Former 10% Owner | Apr 13, 2021 | Sale | $19.46 | 1,943 | 37,806 | 3,223,853 | Apr 15, 2021, 08:01 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Apr 09, 2021 | Sale | $29.99 | 119 | 3,569 | 3,665,787 | Apr 13, 2021, 04:16 PM |
HARP | | Harpoon Therapeutics, Inc. | Luke Evnin | 10% Owner | Apr 09, 2021 | Sale | $23.67 | 10,300 | 243,801 | 3,228,006 | Apr 13, 2021, 04:12 PM |
HARP | | Harpoon Therapeutics, Inc. | Luke Evnin | 10% Owner | Apr 12, 2021 | Sale | $21.02 | 2,496 | 52,460 | 3,226,369 | Apr 13, 2021, 04:12 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Apr 08, 2021 | Sale | $30.52 | 19,304 | 589,089 | 3,666,153 | Apr 09, 2021, 04:10 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Apr 07, 2021 | Sale | $32.55 | 5,783 | 188,254 | 3,703,499 | Apr 09, 2021, 04:10 PM |
HARP | | Harpoon Therapeutics, Inc. | Luke Evnin | 10% Owner | Feb 10, 2021 | Sale | $20.00 | 183,051 | 3,661,020 | 3,238,306 | Feb 12, 2021, 05:03 PM |
HARP | | Harpoon Therapeutics, Inc. | Luke Evnin | 10% Owner | Feb 10, 2021 | Sale | $20.00 | 183,051 | 3,661,020 | 3,238,306 | Feb 12, 2021, 05:03 PM |
HARP | | Harpoon Therapeutics, Inc. | Luke Evnin | 10% Owner | Feb 05, 2021 | Sale | $20.01 | 10,172 | 203,542 | 3,502,885 | Feb 09, 2021, 06:14 PM |
HARP | | Harpoon Therapeutics, Inc. | Luke Evnin | 10% Owner | Feb 08, 2021 | Sale | $20.04 | 72,128 | 1,445,445 | 3,430,757 | Feb 09, 2021, 06:14 PM |
HARP | | Harpoon Therapeutics, Inc. | Luke Evnin | 10% Owner | Feb 09, 2021 | Sale | $20.25 | 9,400 | 190,350 | 3,421,357 | Feb 09, 2021, 06:14 PM |
HARP | | Harpoon Therapeutics, Inc. | Luke Evnin | 10% Owner | Feb 02, 2021 | Sale | $20.13 | 48,421 | 974,715 | 3,584,709 | Feb 04, 2021, 07:30 PM |
HARP | | Harpoon Therapeutics, Inc. | Luke Evnin | 10% Owner | Feb 03, 2021 | Sale | $20.21 | 41,922 | 847,244 | 3,542,787 | Feb 04, 2021, 07:30 PM |
HARP | | Harpoon Therapeutics, Inc. | Luke Evnin | 10% Owner | Feb 04, 2021 | Sale | $20.37 | 29,730 | 605,600 | 3,513,057 | Feb 04, 2021, 07:30 PM |
HARP | | Harpoon Therapeutics, Inc. | Luke Evnin | 10% Owner | Jan 26, 2021 | Sale | $21.08 | 1,363 | 28,732 | 4,339,955 | Jan 27, 2021, 08:35 PM |
HARP | | Harpoon Therapeutics, Inc. | Luke Evnin | 10% Owner | Jan 27, 2021 | Sale | $20.00 | 706,825 | 14,136,500 | 3,633,130 | Jan 27, 2021, 08:35 PM |
HARP | | Harpoon Therapeutics, Inc. | Luke Evnin | 10% Owner | Jan 25, 2021 | Sale | $21.23 | 13,006 | 276,117 | 4,341,318 | Jan 27, 2021, 08:35 PM |
HARP | | Harpoon Therapeutics, Inc. | Luke Evnin | 10% Owner | Jan 20, 2021 | Sale | $24.04 | 17,694 | 425,291 | 4,508,731 | Jan 22, 2021, 08:16 PM |
HARP | | Harpoon Therapeutics, Inc. | Luke Evnin | 10% Owner | Jan 21, 2021 | Sale | $22.22 | 26,066 | 579,095 | 4,384,106 | Jan 22, 2021, 08:16 PM |
HARP | | Harpoon Therapeutics, Inc. | Luke Evnin | 10% Owner | Jan 22, 2021 | Sale | $21.72 | 24,695 | 536,375 | 4,354,324 | Jan 22, 2021, 08:16 PM |
TMPM | | TURMERIC ACQUISITION CORP. | Luke Evnin | Chief Executive Officer | Oct 20, 2020 | Other Acquisition or Disposition | $10.00 | 415,500 | 4,155,000 | 415,500 | Oct 20, 2020, 04:18 PM |
ONCR | | Oncorus, Inc. | Luke Evnin | Director | Oct 06, 2020 | Conversion | - | 2,225,795 | - | 2,341,618 | Oct 08, 2020, 06:27 PM |
ONCR | | Oncorus, Inc. | Luke Evnin | Director | Oct 06, 2020 | Buy | $15.00 | 151,225 | 2,268,375 | 2,492,843 | Oct 08, 2020, 06:27 PM |
DYN | | Dyne Therapeutics, Inc. | Luke Evnin | 10% Owner | Sep 21, 2020 | Conversion | - | 4,951,303 | - | 4,614,943 | Sep 23, 2020, 07:12 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Jul 28, 2020 | Conversion | - | 3,546,663 | - | 1,993,932 | Jul 29, 2020, 09:18 PM |
ITOS | | iTeos Therapeutics, Inc. | Luke Evnin | 10% Owner | Jul 28, 2020 | Buy | $19.00 | 160,000 | 3,040,000 | 2,083,887 | Jul 29, 2020, 09:18 PM |
RPTX | | Repare Therapeutics Inc. | Luke Evnin | 10% Owner | Jun 23, 2020 | Conversion | - | 2,753,772 | - | 2,753,772 | Jun 25, 2020, 04:31 PM |
RPTX | | Repare Therapeutics Inc. | Luke Evnin | 10% Owner | Jun 23, 2020 | Buy | $20.00 | 250,000 | 5,000,000 | 3,003,772 | Jun 25, 2020, 04:31 PM |
TCRR | | TCR2 THERAPEUTICS INC. | Luke Evnin | 10% Owner | Feb 19, 2019 | Conversion | - | 3,148,297 | - | 3,344,199 | Feb 21, 2019, 06:05 PM |
TCRR | | TCR2 THERAPEUTICS INC. | Luke Evnin | 10% Owner | Feb 19, 2019 | Buy | $15.00 | 706,666 | 10,599,990 | 4,050,865 | Feb 21, 2019, 06:05 PM |
HARP | | Harpoon Therapeutics, Inc. | Luke Evnin | Director | Feb 12, 2019 | ATM/ITM Option Exercise | $0.05 | 432,119 | 21,260 | 4,275,949 | Feb 14, 2019, 05:19 PM |
HARP | | Harpoon Therapeutics, Inc. | Luke Evnin | Director | Feb 12, 2019 | Conversion | - | 3,521,767 | - | 3,843,830 | Feb 14, 2019, 05:19 PM |
HARP | | Harpoon Therapeutics, Inc. | Luke Evnin | Director | Feb 12, 2019 | Tax Payment (Shares) | $14.00 | 1,524 | 21,336 | 4,274,425 | Feb 14, 2019, 05:19 PM |
HARP | | Harpoon Therapeutics, Inc. | Luke Evnin | Director | Feb 12, 2019 | Buy | $14.00 | 250,000 | 3,500,000 | 4,524,425 | Feb 14, 2019, 05:19 PM |
RYTM | | RHYTHM PHARMACEUTICALS, INC. | Luke Evnin | 10% Owner | Oct 10, 2017 | Conversion | - | 2,567,014 | - | 2,596,392 | Oct 11, 2017, 02:25 PM |
RYTM | | RHYTHM PHARMACEUTICALS, INC. | Luke Evnin | 10% Owner | Oct 10, 2017 | Buy | $17.00 | 100,000 | 1,700,000 | 2,696,392 | Oct 11, 2017, 02:25 PM |
SNDX | | Syndax Pharmaceuticals Inc | Luke Evnin | Director | Mar 08, 2016 | Conversion | - | 2,168,691 | - | 2,168,691 | Mar 08, 2016, 06:37 PM |
CERC | | Cerecor Inc. | Luke Evnin | 10% Owner | Oct 20, 2015 | Conversion | - | 595,436 | - | 595,436 | Oct 20, 2015, 02:59 PM |
CHMA | | CHIASMA, INC | Luke Evnin | 10% Owner | Jul 21, 2015 | Conversion | - | 5,681,544 | - | 5,681,544 | Jul 21, 2015, 04:32 PM |
RDUS | | Radius Health, Inc. | Luke Evnin | 10% Owner | Jun 06, 2014 | Conversion | - | 4,743,002 | - | 4,743,002 | Jun 10, 2014, 06:34 PM |
TRIV | | TriVascular Technologies, Inc. | Luke Evnin | 10% Owner | Apr 22, 2014 | Conversion | - | 1,776,692 | - | 1,776,692 | Apr 23, 2014, 06:12 PM |
PETX | | ARATANA THERAPEUTICS, INC. | Luke Evnin | 10% Owner | Mar 10, 2014 | Sale | $20.02 | 600,000 | 12,012,000 | 2,751,048 | Mar 12, 2014, 06:55 PM |
EPZM | | Epizyme, Inc. | Luke Evnin | 10% Owner | Feb 10, 2014 | Sale | $29.25 | 466,666 | 13,649,981 | 2,413,819 | Feb 11, 2014, 03:54 PM |
ETRM | | EnteroMedics Inc | Luke Evnin | Director | Jan 08, 2014 | Sale | $2.50 | 284,531 | 711,328 | 1,113,168 | Jan 09, 2014, 04:58 PM |
ETRM | | EnteroMedics Inc | Luke Evnin | Director | Jan 06, 2014 | Sale | $2.50 | 81,720 | 204,300 | 1,588,033 | Jan 09, 2014, 04:58 PM |
ETRM | | EnteroMedics Inc | Luke Evnin | Director | Jan 07, 2014 | Sale | $2.50 | 190,334 | 475,835 | 1,397,699 | Jan 09, 2014, 04:58 PM |